Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.436ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.436ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.436ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.436NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.558ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.558ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.558ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.558NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.518ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.518ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.518ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.518NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.368ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.368ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.368ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.368NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.404ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.404ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.404ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.404NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.306ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.306ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.306ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.306NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.328ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.328ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.328ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.328NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.533ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.533ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.533ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.533NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.525ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.120.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.120.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.120.2 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.528ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.528ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.528ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.528NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-17103.8China
C.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used